Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr;22(4):252-264.
doi: 10.1038/s41575-024-01032-w. Epub 2025 Jan 28.

Coeliac disease: complications and comorbidities

Affiliations
Review

Coeliac disease: complications and comorbidities

Jonas F Ludvigsson et al. Nat Rev Gastroenterol Hepatol. 2025 Apr.

Abstract

Coeliac disease is an autoimmune disease characterized by small intestinal villus atrophy and inflammation upon exposure to gluten. It has a global prevalence of approximately 1%. Although the gluten-free diet can be an effective treatment, this diet is burdensome with practical difficulties and frequent inadvertent gluten exposure. Moreover, there are a variety of potential complications and comorbidities of coeliac disease that might be related to malabsorption and/or chronic immune activation. Overall, individuals with coeliac disease have increased mortality compared with the general population, underscoring the severity of this common disease. Comorbidities and complications that have been associated with coeliac disease include poor growth, reproductive complications, kidney and liver diseases, respiratory disease (such as pneumonia) and infections (including sepsis). Furthermore, coeliac disease has been linked to other autoimmune disease and psychiatric disease, as well as certain cancers. Data suggest that mucosal healing on a gluten-free diet might protect against some, but not all, of these complications. In this Review, we present absolute and relative risks of coeliac-associated disorders. We discuss underlying mechanisms, the role of the gluten-free diet and mucosal healing, as well as implications for follow-up and non-dietary treatment of coeliac disease.

PubMed Disclaimer

Conflict of interest statement

Competing interests: J.F.L. has coordinated an unrelated study on behalf of the Swedish Inflammatory Bowel Disease quality register (SWIBREG). That study received funding from the Janssen Corporation. J.F.L. has also received financial support from Merck Sharp & Dohme to develop a paper reviewing national healthcare registers in China. J.F.L. also has a research collaboration on coeliac disease with Takeda. D.A.L. receives a salary as an employee of Takeda Pharmaceuticals.

References

    1. Lebwohl, B., Sanders, D. S. & Green, P. H. R. Coeliac disease. Lancet 391, 70–81 (2018). - PubMed - DOI
    1. Ludvigsson, J. F. et al. The Oslo definitions for coeliac disease and related terms. Gut 62, 43–52 (2013). - PubMed - DOI
    1. Al-Toma, A. et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. U Eur. Gastroenterol. J. 7, 583–613 (2019). - DOI
    1. Rubio-Tapia, A., Hill, I. D., Semrad, C., Kelly, C. P. & Lebwohl, B. American College of Gastroenterology guidelines update: diagnosis and management of celiac disease. Am. J. Gastroenterol. 118, 59–76 (2023). - PubMed - DOI
    1. Lebwohl, B., Green, P. H. R., Söderling, J., Roelstraete, B. & Ludvigsson, J. F. Association between celiac disease and mortality risk in a Swedish population. JAMA 323, 1277–1285 (2020). - PubMed - PMC - DOI

LinkOut - more resources